22 Mar,2024
BY : Maverick Braxton
0 Comments
The United States Food and Drug Administration (FDA) has recently taken a significant step in the battle against COVID-19 by announcing the clearance of the first over-the-counter (OTC) rapid antigen test for COVID-19. This noteworthy development introduces the Flowflex COVID-19 Antigen Home Test, innovatively developed by ACON Laboratories, as a reliable, accessible testing option for the general public. The test, having successfully navigated the traditional FDA premarket review pathway, emerges as the second at-home COVID-19 test to achieve this feat. Notably, this clearance is not merely a routine authorization; it signals a remarkable advancement in the field of diagnostic tools, especially in the context of infectious diseases.
LATEST POST
Shingles and Your Liver: What You Need to Know
29 Apr 2023 | 07:52 AM
Clopidogrel for Children: Safety, Dosage, and Considerations
30 Apr 2023 | 04:25 AM
Navigating the World of Online Dostinex Purchases: A Comprehensive Guide
18 Jan 2024 | 13:30 PM
Top 10 ZipHealth Alternatives in 2024 for Affordable Online Health Services
19 Oct 2024 | 06:49 AM
FDA Approves First OTC Rapid Antigen COVID-19 Test for Home Use
22 Mar 2024 | 05:46 AM
Write a comment